GEORGETOWN UNIVERSITY

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 115142
 
 
 
C07D HETEROCYCLIC COMPOUNDS 38124
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 32135
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 30176
 
 
 
G06F ELECTRIC DIGITAL DATA PROCESSING 27420
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 25100
 
 
 
C07K PEPTIDES 24112
 
 
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 19221
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 18120
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1683

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0055,785 MINT MASK AND METHODS OF USE THEREOFAug 29, 17Mar 01, 18[A61K, A61M]
2018/0053,973 STRIPLINE DETECTOR FOR IN SITU BATTERY AND FUEL CELL NMRAug 21, 17Feb 22, 18[H01M, G01N, G01R]
2017/0365,183 INTELLIGENT MEDICAL HYPERTEXT INFORMATION TRANSLATORJun 16, 17Dec 21, 17[G09B, G06F]
2017/0351,742 Application Programming Interface and Hypergraph Transfer Protocol Supporting a Global Hypergraph Approach to Reducing Complexity For Accelerated Multi-Disciplinary Scientific DiscoveryJun 05, 17Dec 07, 17[G06N, G06F]
2017/0326,114 COGNITIVE FUNCTIONMay 22, 17Nov 16, 17[A61K]
2017/0299,549 System and Method For the Separation of AnalytesJul 03, 17Oct 19, 17[G01N]
2017/0246,259 Compositions and Methods of Using Interleukin-4 Induced Gene 1 (IL-4I1)Sep 09, 15Aug 31, 17[A61K, C12Q, G01N]
2017/0216,287 TREATING NEURAL DISEASE WITH TYROSINE KINASE INHIBITORSMay 06, 16Aug 03, 17[A61K]
2017/0192,018 METABOLIC BIOMARKERS FOR MEMORY LOSSMay 27, 15Jul 06, 17[G01N]
2017/0183,733 GENETIC MARKERS FOR MEMORY LOSSMay 28, 15Jun 29, 17[C12Q]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9889131 Cadherin-11 inhibitors and methods of use thereofFeb 05, 16Feb 13, 18[A61K, C07D, C07K]
9890137 2-halo-5-alkynyl-pyridyl nicotinic ligandsMar 26, 14Feb 13, 18[C07D]
9878055 Treatment for exposure to nerve agentMar 13, 14Jan 30, 18[A61K, C12N, C07K]
9849192 Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodiesMar 18, 16Dec 26, 17[A61K, C07K]
9827307 Use of herpes vectors for tumor therapyFeb 15, 13Nov 28, 17[A61K, C12N]
9815746 Stereodynamic chemosensorsMar 14, 14Nov 14, 17[C07D, C07C, C07B]
9789160 Treatments for lowering glucose levels using FGF binding protein 3Sep 14, 15Oct 17, 17[A61K]
9778223 System and method for the separation of analytesSep 25, 14Oct 03, 17[G01N]
9758481 Targeting of EWS-FLI1 as anti-tumor therapyApr 24, 15Sep 12, 17[A61K, C07D, C07K]
9746985 System and method for detecting, collecting, analyzing, and communicating event-related informationApr 20, 11Aug 29, 17[G06F]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0165,254 TREATING FLAVIVIRUS INFECTIONS WITH AMODIAQUINE AND DERIVATIVES THEREOFAbandonedFeb 05, 15Jun 15, 17[A61K]
2017/0000,746 METHODS FOR TREATING HEAT STRESS AND RELATED COMPOSITIONSAbandonedSep 14, 16Jan 05, 17[A61K]
2016/0038,526 TREATMENT OF PROSTATE CANCERAbandonedMay 10, 13Feb 11, 16[A61K, A61N]
2016/0000,762 IMPROVING COGNITIVE FUNCTIONAbandonedFeb 27, 14Jan 07, 16[A61K]
2015/0311,556 PLATINUM ADLAYERED RUTHENIUM NANOPARTICLES, METHOD FOR PREPARING, AND USES THEREOFAbandonedJul 08, 15Oct 29, 15[H01M]
2015/0252,372 PREPARATION OF ANTIBODY OR AN ANTIBODY FRAGMENT TARGETED IMMUNOLIPOSOMES FOR SYSTEMIC ADMINISTRATION OF THERAPEUTIC OR DIAGNOSTIC AGENTS AND USES THEREOFAbandonedApr 24, 15Sep 10, 15[A61K, C12N, C07K]
2015/0196,530 Use of Artemisinin for Treating Tumors Induced by Oncogenic Viruses and for Treating Viral InfectionsAbandonedJan 26, 15Jul 16, 15[A61K]
2015/0086,648 METHODS FOR TREATING HEAT STRESS AND RELATED COMPOSITIONSAbandonedOct 07, 14Mar 26, 15[A61K]
2014/0341,965 Compositions and Methods Comprising Biodegradable Scaffolds and Retinal Pigment Epithelial CellsAbandonedMar 14, 14Nov 20, 14[A61K, C12N, A61L]
2014/0322,809 Use of a Rock Inhibitor to Sustain Primary Human Keratinocytes in a Proliferative StateAbandonedNov 20, 13Oct 30, 14[C12N]
2014/0294,845 ANTI-PLEIOTROPHIN ANTIBODIES AND METHODS OF USE THEREOFAbandonedFeb 03, 14Oct 02, 14[A61K, C07K]
2014/0287,409 Detection And Assessment Of Cancer Risk Using Telomere HealthAbandonedMar 14, 14Sep 25, 14[C12Q]
2014/0243,319 TREATMENTS TARGETING GAMMA-SYNUCLEIN EXPRESSION LEVELSAbandonedMar 16, 12Aug 28, 14[A61K, G01N]
2014/0178,296 TUMOR-TARGETED NANODELIVERY SYSTEMS TO IMPROVE EARLY MRI DETECTION OF CANCERAbandonedDec 06, 13Jun 26, 14[A61K]
2014/0134,564 ARCH BARS FOR USE IN MAXILLOFACIAL SURGERY AND ORTHODONTICSAbandonedJan 21, 14May 15, 14[A61C]
2014/0121,485 Electrochemical Transdermal Glucose Measurement System Including Microheaters and Process For FormingAbandonedApr 30, 12May 01, 14[C25D, A61B]
2014/0094,384 STROMAL ANTIGEN 2 (STAG2) COMPOSITIONS AND METHODSAbandonedNov 25, 13Apr 03, 14[C12Q, C12N, G01N, C07K]
2014/0066,384 NOVEL GENES AND PROTEINS THAT HOME TO DEVELOPING MICROVESSELSAbandonedApr 15, 13Mar 06, 14[C07K]
2014/0044,873 SINGLE-WALLED CARBON NANOTUBE (SWCNT) FABRICATION BY CONTROLLED CHEMICAL VAPOR DEPOSITION (CVD)AbandonedAug 10, 12Feb 13, 14[C23C, B82Y]
2013/0324,543 REVERSAL OF HIGH BREAST CANCER RISK IN MAMMALS EXPOSED TO ESTROGENIC CHEMICALS IN UTERO BY ADULT EXPOSURE TO HDAC AND DNMT INHIBITORSAbandonedApr 05, 13Dec 05, 13[C12Q]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.